Abstract
Bloodstream infection (BSI) and sepsis require rapid pathogen identification and timely antimicrobial optimisation, yet conventional blood culture is limited by prolonged turnaround time and imperfect sensitivity. Rapid molecular technologies have therefore emerged as complementary diagnostic approaches for accelerating pathogen detection and, in selected platforms, resistancemarker identification. This narrative review synthesises evidence on two clinically important technologies: culture-independent T2 magnetic resonance (T2MR) testing, represented by T2Bacteria and T2Candida, and culture-based multiplex Polymerase Chain Reaction (PCR), represented by the BioFire Blood Culture Identification 2 (BCID2) panel. Evidence indicates that T2MR can substantially reduce time to pathogen detection and antimicrobial optimisation compared with conventional blood culture, while BCID2 demonstrates high sensitivity and specificity for several clinically important bloodstream pathogens and selected resistance determinants. Real-world studies suggest that rapid molecular results can support antimicrobial escalation, de-escalation and stewardship decisions; however, clinical benefit depends on panel coverage, baseline laboratory turnaround, local epidemiology and effective stewardship infrastructure. These technologies should not be considered replacements for conventional blood culture, which remains essential for broad organism recovery, phenotypic antimicrobial susceptibility testing and detection of pathogens outside molecular panels. An integrated diagnostic pathway combining rapid molecular testing with conventional culture may therefore provide the greatest clinical value. Future priorities include expanded pathogen and resistance coverage, prospective multicentre outcome studies, costeffectiveness analyses and implementation research in resource-limited settings.
Keywords: Bloodstream infection, Sepsis, Point-of-care testing, Nucleic acid amplification test, T2 magnetic resonance, BioFire BCID2, Multiplex PCR, Antimicrobial stewardship